Katie Tinkler, lupus patient, receives 'groundbreaking' treatment

Interview with Katie Tinkler, one of three patients receiving a ”groundbreaking” treatment for lupus on the NHS, which experts hope could eradicate the need for lifelong drugs. In the new NHS trial, led by University College London Hospitals NHS Foundation Trust (UCLH) and University College London (UCL), three patients have received CAR T-cell therapy for the most serious form of lupus, a condition that can be life-threatening and cause damage to the heart, lungs, brain and kidneys. Early indications are that the therapy – which only needs to be given once – could “revolutionise treatment” and remove the need for lifelong medication.